Treatment for Nontype 1 Retinopathy of Prematurity by Intravitreal Injection of Antivascular Endothelial Growth Factor Drugs

Table 2

Comparison of effects for the eyes with type 1 and nontype 1 ROP after intravitreal injection of anti-VEGF drugs (N  = 262).

	Nontype 1 ROP eyes	Type 1 ROP eyes	χ^2 value^α	P
Cured	27 (41.5)	79 (40.1)	6.514	0.02
Improved	38 (58.5)	100 (50.8)
Recurrence	0 (0.0)	18 (9.1)
Total	65 (100)	197 (100)